| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.7M | +18.9% |
| SG&A Expense | $1.6M | +4.1% |
| Operating Income | -$9.3M | -16.0% |
| Net Income | -$8.9M | -13.6% |
| EPS (Basic) | -$0.69 | -13.1% |
| EPS (Diluted) | -$0.69 | -13.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -48.1% |
| Total Assets | $7.0M | -48.1% |
| Current Liabilities | $294K | +12.0% |
| Total Liabilities | $294K | +12.0% |
| Stockholders' Equity | $6.7M | -49.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.5M | -4.5% |
| Financing Cash Flow | -$7.5M | +0.0% |